These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10282092)

  • 1. Ethical concerns arising from industry/practitioner relationship.
    Hall K
    Can J Hosp Pharm; 1987 Apr; 40(2):73-4. PubMed ID: 10282092
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug detailing in the hospital: background for policy development.
    Chan J; Einarson T
    Can J Hosp Pharm; 1991 Jun; 44(3):161-6. PubMed ID: 10112744
    [No Abstract]   [Full Text] [Related]  

  • 3. Policy and procedure manual. Medical service representatives.
    Curr Concepts Hosp Pharm Manage; 1987; 9(2):19-20. PubMed ID: 10282080
    [No Abstract]   [Full Text] [Related]  

  • 4. Hospital pharmacy and industry--conflict and collaboration.
    Gouveia WA
    Am J Hosp Pharm; 1984 Jul; 41(7):1391-4. PubMed ID: 6465157
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimizing the influence of drug marketing.
    Hester FG
    Hospitals; 1990 Aug; 64(15):80. PubMed ID: 2373503
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug diversion by hospitals.
    Provost GP
    Am J Hosp Pharm; 1968 Apr; 25(4):159. PubMed ID: 5655783
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of a hospital pharmacy drug product selection program.
    Gurwich E; Eck TA
    Curr Concepts Hosp Pharm Manage; 1983; 5(2):6-10. PubMed ID: 10260706
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug samples in the hospital revisited.
    Lipman AG
    Hosp Formul; 1987 Feb; 22(2):123. PubMed ID: 10280288
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality control of drugs.
    Whittet TD
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:15-9. PubMed ID: 5701292
    [No Abstract]   [Full Text] [Related]  

  • 10. Adequate and sensible quality control.
    Schoulund B
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:21. PubMed ID: 5701294
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical sales representatives.
    Tatro DS; Miller RF
    Hosp Formul; 1983 Apr; 18(4):466. PubMed ID: 10259513
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospital policies on pharmaceutical sales representatives' activities.
    Oddis JA
    Resid Staff Physician; 1987 Sep; 33(10):8. PubMed ID: 10284382
    [No Abstract]   [Full Text] [Related]  

  • 13. New ethical requirements at the NIH: implications for CIHR and Canada.
    Bernstein A
    CMAJ; 2005 Aug; 173(4):353-4. PubMed ID: 16103503
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospital pharmacy--a not so visible profession.
    McDermott D
    Can J Hosp Pharm; 1978; 31(1):5. PubMed ID: 10306175
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital procedures for a drug recall.
    Dimens Health Serv; 1978 Mar; 55(3):34-5. PubMed ID: 640284
    [No Abstract]   [Full Text] [Related]  

  • 16. One hospital's rules for pharmaceutical sales representatives.
    Hethcox JM
    Hosp Formul; 1977 Feb; 12(2):112, 115-6. PubMed ID: 10305394
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicine's "gray market"': why alarm bells are ringing.
    Gest T; Lanier LK
    US News World Rep; 1985 Dec; 99(23):52. PubMed ID: 10274713
    [No Abstract]   [Full Text] [Related]  

  • 18. Reporting drug product defects--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacy ethics in the '80s.
    Schendt RL
    Curr Concepts Hosp Pharm Manage; 1983; 5(1):16-8. PubMed ID: 10258528
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug manufacturing in hospitals.
    Gillespie BJ
    Can J Hosp Pharm; 1985 Apr; 38(2):42. PubMed ID: 10270940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.